Microbiome-driven carcinogenesis in colorectal cancer: Models and mechanisms
- PMID: 27810411
- DOI: 10.1016/j.freeradbiomed.2016.10.504
Microbiome-driven carcinogenesis in colorectal cancer: Models and mechanisms
Abstract
Colorectal cancer (CRC) is a leading cause of cancer death and archetype for cancer as a genetic disease. However, the mechanisms for genetic change and their interactions with environmental risk factors have been difficult to unravel. New hypotheses, models, and methods are being used to investigate a complex web of risk factors that includes the intestinal microbiome. Recent research has clarified how the microbiome can generate genomic change in CRC. Several phenotypes among a small group of selected commensals have helped us better understand how mutations and chromosomal instability (CIN) are induced in CRC (e.g., toxin production, metabolite formation, radical generation, and immune modulation leading to a bystander effect). This review discusses recent hypotheses, models, and mechanisms by which the intestinal microbiome contributes to the initiation and progression of sporadic and colitis-associated forms of CRC. Overall, it appears the microbiome can initiate and/or promote CRC at all stages of tumorigenesis by acting as an inducer of DNA damage and CIN, regulating cell growth and death, generating epigenetic changes, and modulating host immune responses. Understanding how the microbiome interacts with other risk factors to define colorectal carcinogenesis will ultimately lead to more accurate risk prediction. A deeper understanding of CRC etiology will also help identify new targets for prevention and treatment and help accelerate the decline in mortality for this common cancer.
Keywords: Cancer etiology; Cancer stem cell; Colon cancer; DNA damage; Microbiome; Mutagenesis.
Published by Elsevier Inc.
Similar articles
-
It takes a village: microbiota, parainflammation, paligenosis and bystander effects in colorectal cancer initiation.Dis Model Mech. 2021 May 1;14(5):dmm048793. doi: 10.1242/dmm.048793. Epub 2021 May 10. Dis Model Mech. 2021. PMID: 33969420 Free PMC article. Review.
-
Colorectal cancer: role of commensal bacteria and bystander effects.Gut Microbes. 2015;6(6):370-6. doi: 10.1080/19490976.2015.1103426. Gut Microbes. 2015. PMID: 26727419 Free PMC article. Review.
-
Role of Microbiome in Carcinogenesis Process and Epigenetic Regulation of Colorectal Cancer.Methods Mol Biol. 2018;1856:35-55. doi: 10.1007/978-1-4939-8751-1_3. Methods Mol Biol. 2018. PMID: 30178245 Review.
-
Evolutionary biologic changes of gut microbiota in an 'adenoma-carcinoma sequence' mouse colorectal cancer model induced by 1, 2-Dimethylhydrazine.Oncotarget. 2017 Jan 3;8(1):444-457. doi: 10.18632/oncotarget.13443. Oncotarget. 2017. PMID: 27880935 Free PMC article.
-
Microbiota, Inflammation and Colorectal Cancer.Int J Mol Sci. 2017 Jun 20;18(6):1310. doi: 10.3390/ijms18061310. Int J Mol Sci. 2017. PMID: 28632155 Free PMC article. Review.
Cited by
-
Gut Bacteria Provide Genetic and Molecular Reporter Systems to Identify Specific Diseases.Int J Mol Sci. 2024 Apr 17;25(8):4431. doi: 10.3390/ijms25084431. Int J Mol Sci. 2024. PMID: 38674014 Free PMC article. Review.
-
Tumor Microbial Communities and Thyroid Cancer Development-The Protective Role of Antioxidant Nutrients: Application Strategies and Future Directions.Antioxidants (Basel). 2023 Oct 23;12(10):1898. doi: 10.3390/antiox12101898. Antioxidants (Basel). 2023. PMID: 37891977 Free PMC article. Review.
-
Ecological niches for colorectal cancer stem cell survival and thrival.Front Oncol. 2023 Apr 13;13:1135364. doi: 10.3389/fonc.2023.1135364. eCollection 2023. Front Oncol. 2023. PMID: 37124519 Free PMC article. Review.
-
Prevention of malignant digestive system tumors should focus on the control of chronic inflammation.World J Gastrointest Oncol. 2023 Mar 15;15(3):389-404. doi: 10.4251/wjgo.v15.i3.389. World J Gastrointest Oncol. 2023. PMID: 37009320 Free PMC article. Review.
-
Antitumor effects of fecal microbiota transplantation: Implications for microbiome modulation in cancer treatment.Front Immunol. 2022 Sep 13;13:949490. doi: 10.3389/fimmu.2022.949490. eCollection 2022. Front Immunol. 2022. PMID: 36177041 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical